Expensive IPO....definitely not worth the money, look at the salaries and directors fees... ridiculous.
Would probably get better value out of buying Oncosil...
I wonder if Chris is still pursuing self promotion through his research company now that he is in "real" business.
Hopefully his contribution will be more meaningful to Telix compared to Factor therapeutics.
At least Andreas Kluge is a respected professional.
TLX a concoction of licenses yet to be paid.....Wishful thinking in a full moon, tranquil August night.
Best of luck to the investors
IPO - Telix Pharmaceuticals Limited, page-2
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
0.440(2.97%) |
Mkt cap ! $5.036B | |||
| Open | High | Low | Value | Volume |
| $14.71 | $15.24 | $14.61 | $17.69M | 1.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2333 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.21 |
Change
0.440 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| $14.73 | $15.24 | $14.62 | 327752 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| TLX (ASX) Chart |